What's new

China Dominates the Global Antibiotics Market

beijingwalker

ELITE MEMBER
Joined
Nov 4, 2011
Messages
65,193
Reaction score
-55
Country
China
Location
China

China Dominates the Global Antibiotics Market​

HEALTH

by Martin Armstrong,
Jul 1, 2022

Global exports of antibiotics originate predominantly from China - as shown in this infographic based on data from the International Trade Center (ITC). China currently accounts for 42.4 percent of global antibiotic exports by value. Italy, India and Switzerland follow far behind.

For years, experts have been warning of the EU's dependence on antibiotic supplies from abroad, especially China and India. This dependence is not only limited to antibiotics, but affects - also for many years - a wide range of pharmaceutical products, including cortisone, for example.

In addition, the world is facing another, increasingly significant problem: More and more bacteria are developing resistance to common antibiotics. As a result, there is now a pressing need for drugs that are specifically effective against resistant germs.

Most of the antibiotic classes introduced in the 21st century do just that. However, research into these active substances is often not profitable and risky for the industry; because drugs that specifically act against resistant germs are not used across the board, but only as so-called "second-line" or "last-line" antibiotics (reserve antibiotics) - as a last resort when the established drugs are no longer effective.

27709.jpeg
 
Without Chinese drugs and PPEs, Americans and Europeans will literally die like flies

newyorkpost_03262020.jpg
 

China Dominates the Global Antibiotics Market​

HEALTH

by Martin Armstrong,
Jul 1, 2022

Global exports of antibiotics originate predominantly from China - as shown in this infographic based on data from the International Trade Center (ITC). China currently accounts for 42.4 percent of global antibiotic exports by value. Italy, India and Switzerland follow far behind.

For years, experts have been warning of the EU's dependence on antibiotic supplies from abroad, especially China and India. This dependence is not only limited to antibiotics, but affects - also for many years - a wide range of pharmaceutical products, including cortisone, for example.

In addition, the world is facing another, increasingly significant problem: More and more bacteria are developing resistance to common antibiotics. As a result, there is now a pressing need for drugs that are specifically effective against resistant germs.

Most of the antibiotic classes introduced in the 21st century do just that. However, research into these active substances is often not profitable and risky for the industry; because drugs that specifically act against resistant germs are not used across the board, but only as so-called "second-line" or "last-line" antibiotics (reserve antibiotics) - as a last resort when the established drugs are no longer effective.

27709.jpeg
Wow Italy number 2
Even though no Italian pharma giants come to mind like GSK of UK and Merck Bayer of Germany

Or is this the very reason big pharma shifting production to other countries where laws are more favourable
 
Wow Italy number 2
Even though no Italian pharma giants come to mind like GSK of UK and Merck Bayer of Germany

Or is this the very reason big pharma shifting production to other countries where laws are more favourable
Antibiotics is a very small market, because Antibiotics cure diseases, which means it's not as profitable as drugs that do not cure diseases and therefore have to be taken forever.

Curing illnesses is for suckers.
 
Back
Top Bottom